Selective dual cholinesterase inhibitors from Aconitum laeve

Abstract New lycoctonine-type dual cholinesterase inhibitor, swatinine-C (1), along with three known norditerpenoid alkaloids, hohenackerine (2), aconorine (5) and lappaconitine (6) and two synthetically known but phytochemically new benzene derivatives, methyl 2-acetamidobenzoate (3) and methyl 4-[2-(methoxycarbonyl)anilino]-4-oxobutanoate (4), was isolated from the roots of A. laeve. Structures of new and known compounds (1–6) were established on the basis of latest spectroscopic techniques and by close comparison with the data available in literature. In vitro, compounds (1–6) were tested against AChE and BChE inhibitory activities. Compounds 1 and 2 showed competitive inhibition against AChE (IC50 = 3.7 μM, 4.53 μM) and BChE (IC50 = 12.23 μM, 9.94 μM), respectively. Compounds 5 and 6 showed promising noncompetitive type of inhibitory profile against AChE (IC50 = 2.51 and 6.13 μM) only. Compounds 3 and 4 showed weak inhibitory profile against both AChE and BChE.

[1]  G. Brockmann,et al.  Arch , 2020, Definitions.

[2]  67 , 2018, Tao te Ching.

[3]  Manzoor Ahmad,et al.  Isolation, crystal structure determination and cholinesterase inhibitory potential of isotalatizidine hydrate from Delphinium denudatum , 2016, Pharmaceutical biology.

[4]  S. Pyo,et al.  Inhibitory Effect of Methyl 2-(4'-Methoxy-4'-oxobutanamide) Benzoate from Jerusalem Artichoke (Helianthus tuberosus) on the Inflammatory Paracrine Loop between Macrophages and Adipocytes. , 2016, Journal of agricultural and food chemistry.

[5]  M. Hutchby.  Novel Synthetic Chemistry of Ureas and Amides , 2012 .

[6]  X. Cen,et al.  Mechanism study of Aconitum-induced neurotoxicity in PC12 cells: involvement of dopamine release and oxidative damage. , 2010, Neurotoxicology.

[7]  S. Ojha,et al.  Anti-inflammatory activity of Aconitum heterophyllum on cotton pellet-induced granuloma in rats , 2010 .

[8]  Manzoor Ahmad,et al.  Norditerpenoid alkaloids from the roots of Aconitum heterophyllum Wall with antibacterial activity , 2008 .

[9]  M. Sultankhodzhaev,et al.  Alkaloids of Aconitum kirinense. Structure of akirine , 1992, Chemistry of Natural Compounds.

[10]  V. A. Tel'nov,et al.  Alkaloids ofDelphinium iliense , 1977, Chemistry of Natural Compounds.

[11]  C. Geula,et al.  Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.

[12]  M. Mesulam,et al.  Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine , 2002, Neuroscience.

[13]  C. Ballard,et al.  Advances in the Treatment of Alzheimer’s Disease: Benefits of Dual Cholinesterase Inhibition , 2002, European Neurology.

[14]  N. Greig,et al.  Synthesis of novel phenserine-based-selective inhibitors of butyrylcholinesterase for Alzheimer's disease. , 1999, Journal of medicinal chemistry.

[15]  D. Rhee,et al.  Isolation of a multidrug resistance inhibitor fromAconitum pseudo-laeve var.erectum , 1998, Archives of pharmacal research.

[16]  J. Clardy,et al.  Antifungal diterpenoid alkaloids from Delphinium denudatum. , 1997, Journal of natural products.

[17]  J. Sullivan,et al.  Lycaconitine revisited: partial synthesis and neuronal nicotinic acetylcholine receptor affinities. , 1996, Journal of natural products.

[18]  H. Soreq,et al.  Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons. , 1995, Pharmacology & therapeutics.

[19]  T. Emanuelli,et al.  Effects of early undernutrition on kinetic parameters of brain acetylcholinesterase from adult rats. , 1993, Acta neurobiologiae experimentalis.

[20]  E. Perry,et al.  Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[21]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.